Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 2004, p. 766-769, Vol. 11, No. 4
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.4.766-769.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Oral Biology,1 Division of Infectious Diseases, Department of Medicine, and the Ruy V. Lourenço Center for the Study of Emerging and Reemerging Pathogens, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103-27142
Received 20 December 2003/ Returned for modification 17 February 2004/ Accepted 19 March 2004
|
|
|---|
G transversion in the DEFB1 gene (which encodes human ß-defensin 1) has been previously associated with Candida carriage in oral epithelia. In this study, we analyzed the association between early-onset periodontal disease (EOP) and the 44 SNP. We used an HP assay to study the distribution of the 44 SNP in 264 human DNAs obtained from two cohorts of EOP patients and healthy controls from different ethnic backgrounds. The results indicate that the 44 SNP has a similar distribution between EOP and healthy patients, suggesting that it is not associated with the disease. |
|
|---|
Most of the methods available for SNP detection, such as techniques based on mass spectrometry (20), high-pressure liquid chromatography (23), microarray analysis (6), Taqman probes (16), or molecular beacons (25), are generally costly, time consuming, and/or difficult to automate, hindering their implementation in most laboratories.
The recently developed hairpin-shaped primer (HP) assay is a feasible alternative method for SNP detection, which is easy to implement in a wide variety of laboratories (10). This method offers an improved specificity over conventional amplification refractory mutation system (ARMS) assays (22) because it uses primers that carry a 5'-end nucleotide tail complementary to the 3' end of the SNP-detecting primer, creating a hairpin structure. This prevents nonspecific priming. The 3' end of the HP hybridizes to the SNP residue. Two HPs are designed, one complementary to each allele, together with a common linear primer. Two PCRs are performed in parallel, each with one of the two HPs, using the same DNA template, and the amplification is monitored in real time, by fluorescence increase, using the free fluorophore SYBR green I. An HP that is fully complementary to the target DNA will yield a more efficient amplification than a mismatched reaction, leading to an earlier threshold cycle (Ct). The greater the difference between the Cts of the mismatched and matched primer-template reactions (
Ct) for each HP, the more robust the assay is. The technique has been developed and proven to be effective in prokaryotic contexts (10). This study presents the first report of the application of a HP assay to SNP genotyping in a human disease.
Early-onset periodontal disease (EOP) is a complex multifactorial disorder triggered by colonization of the oral epithelia by bacteria and yeasts, which leads to a gingival inflammation, loss of alveolar bone, and tooth loss (27). The importance of the protective role played by ß-defensins against pathogenic microorganisms in oral epithelia has been discussed by several authors (5, 15, 18). Moreover, a recent observation by Putsep et al. on patients suffering from morbus Kostmann (24) highlights the role of antimicrobial peptides in periodontal disease. Epidemiological studies clearly demonstrate that genetic factors play a significant role in EOP (9, 21), underscoring the importance of applying genetics approaches to study EOP. The C
G transversion at position 44 of the DEFB1 gene (which encodes human ß-defensin 1) has been associated with Candida sp. carriage in the mouth (12) and with the risk of human immunodeficiency virus type 1 infection in the Caucasian population (1).
In order to establish if the 44 SNP is associated with EOP, we studied its distribution in EOP patients and healthy controls from two different ethnic backgrounds, using the HP assay.
|
|
|---|
PCRs. Primers were designed using the Primer Express 2.0 software (ABI, Foster City, Calif.), with reference to the published human genome sequence (GenBank accession number U50930). A tail was added to the 5' end of the SNP-specific primers in order to produce a stem with a melting temperature (Tm) of 67 to 70°C and a variation of free energy of between 0.5 and 2.0, using the mfold software (http://www.bioinfo.rpi.edu/applications/mfold/old/dna/).
Sequences of the forward C- and G-allele-specific HPs are GGCTGGACCTCCAAtGGAGCCAGCC and CGCTGGACCTCCAAtGGAGCCAGCG, respectively, where the underlined residues correspond to the 5'-end tails, the bold upper-case corresponds to the 3' SNP-specific residue, and the lowercase corresponds to a secondary mutation inserted to improve the discriminatory power of the assay. When used with the common reverse primer (CAGGATTTCAGGAACTGGGGAG), the PCR yields a 45-bp amplicon. For each DNA sample, two real-time PCRs of 10 µl were run in parallel, one with the C-allele-specific HP and the other with the G-allele-specific HP. Each reaction contained 1x PCR buffer II (ABI); 200 µM concentration each of dATP, dCTP, dGTP, and dTTP; 0.3 U of AmpliTaq Gold (ABI); 2 mM MgCl2; 5 pmol (each) primer; 1x SYBR Green I; 1.75 ng of 6-carboxy X-rhodamine; succinimidyl ester (Molecular Probes, Eugene, Ore.); and 10 ng of template DNA. All PCRs were run in a Stratagene MX4000 real-time PCR instrument (Stratagene, La Jolla, Calif.). Thermal cycling conditions were as follows: stage 1, 95°C for 10 min, 70°C for 30 s; stage 2, 72°C for 30 s, 95°C for 20 s, 69°C for 30 s (lowering 1°C each cycle) for 10 cycles; stage 3, 72°C for 30 s, 95°C for 20 s, 60°C for 30 s for 40 cycles. Data were collected in the last step of stage 3 in order to calculate the Ct of each amplification curve.
As controls, we designed two 45-bp single-stranded oligonucleotide artificial templates, which match the target sequence of each allele: tcagcctccaaaggagccagcC/Gtctccccagttcctgaaatcctg (the residues shown in bold uppercase correspond to the SNP residues). For homozygous controls, each oligonucleotide was used separately as the template for a PCR (using 106 molecules/reaction). A 1:1 mix of both oligonucleotides was used as a C/G heterozygous control, combining 5 x 105 molecules of each per reaction.
DNA sequencing reactions.
PCR amplification of the specific region containing 44 C
G was performed under the conditions previously described by Jurevic et al. (13). DNA sequences were obtained with the Big Dye Terminator sequencing kit (ABI), following the manufacturer's instructions.
Statistical analyses. The mean Cts and the 95% confidence intervals (CI) were calculated using Microsoft Excel (Microsoft Corporation, Redmond, Wash.).
Gene frequencies were calculated from the observed number of genotypes. The significance of differences in allelic and genotypes frequencies was calculated by a
2 test by using 2 x 2 and 3 x 2 contingency tables.
|
|
|---|
![]() View larger version (12K): [in a new window] |
FIG. 1. HP assay for detection of the 44 DEFB1 SNP. Real-time PCR results using chromosomal DNA extracted from blood from two homozygous (C/C and G/G) patients and a heterozygous (C/G) patient. Amplifications using the C-allele HP are represented by closed triangles ( ), and the G-allele HP is represented by open circles ( ).
|
Cts of 11.6, 0.3, and 7.7, respectively. Results are summarized in Table 1. |
View this table: [in a new window] |
TABLE 1. Average Cts for the two different HPs for the three genotypes on human genomic DNAa
|
G transversion at position 44 of the DEFB1 gene. Five samples for each genotype were selected for this purpose. Sequencing data agrees with the HP assay in all cases (data not shown). Genotype and allele frequencies for the four populations studied are shown in Table 2. All the cohorts agree with the Hardy-Weinberg law, further confirming the reliability of the assay. No significant differences were observed in the allele or genotype frequencies at position 44 of the DEFB1 gene among patients suffering from EOP versus healthy controls in the two ethnic populations studied. The C-allele frequency for the Caucasian (23%) and African American (5%) healthy controls agrees with previously reported data by Jurevic et al. (13).
|
View this table: [in a new window] |
TABLE 2. Allele and genotype frequencies in the populations studied
|
|
|
|---|
The HP assay was designed using the conditions recommended by Hazbón and Alland (10) and required no further modifications, illustrating the robustness of the technique. A secondary mutation was introduced in the HPs to avoid an undesired secondary structure. Secondary mutations have also been reported to improve the discriminatory power of the assay (3, 10, 22, 29).
The use of the SYBR Green I chemistry for the detection of the amplicons in a real-time PCR instrument, instead of expensive fluorophore-labeled probes, decreases the cost of the assay to an estimated $0.27 per genotype. Recently, new techniques based on the analysis of the melting profile of the amplicon have been developed for single-tube genotyping, using SYBR Green I chemistry in a real-time instrument. However, most of them require post-PCR manipulation (17) (increasing the risk of cross contamination) or a time-consuming data handling process (11). Germer and Higuchi (7) proposed a protocol for SNP frequency studies, based on ARMS, followed by a melting profile of the amplicons, but it requires a demanding optimization process, which our technique does not.
Sequencing data confirmed the results obtained with our HP assay. Using a 96-well format, we were able to test the 264 samples in only 6 PCR runs (each of which lasts 2 h). These results confirm the potential of the HP assay for medium- to large-scale association studies of complex human diseases.
We applied this technique to study whether there was an association between the C
G transversion at position 44 in the DEFB1 gene and EOP. The results do not support a direct association of this SNP with EOP. It is possible that other SNPs in the DEFB1 gene could be associated with EOP. However, there are no reported associations of other polymorphisms in the DEFB1 gene with an increased risk of infection, with the exception of a nonsynonymous mutation, associated with chronic obstructive pulmonary disease, that has been reported only in a Japanese population (19). It is also possible that human beta-defensin 1 is not active against periodontal bacteria and does not play a role in this disease. Supporting this hypothesis, it has been demonstrated that Treponema denticola is resistant to human beta-defensin 1 (2). Unfortunately, no data are available regarding the biological activity of this peptide against Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis, two key oral pathogens implicated in periodontal disease.
In conclusion, we have designed and optimized a simple, reliable assay for examining SNP frequencies that provides several major advantages over traditional SNP-detecting techniques. We have successfully applied this technique to examine, for the first time, the associations between the SNP at position 44 in the DEFB1 gene and EOP.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»